ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.

Ronald Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.